Literature DB >> 29531901

Next-generation molecular therapy in lung cancer.

Jun Qian1,2, Pierre P Massion1,2.   

Abstract

Entities:  

Year:  2018        PMID: 29531901      PMCID: PMC5835629          DOI: 10.21037/tlcr.2018.01.03

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN: 2218-6751


× No keyword cloud information.
  21 in total

1.  Rational design of small molecule inhibitors targeting the Ras GEF, SOS1.

Authors:  Chris R Evelyn; Xin Duan; Jacek Biesiada; William L Seibel; Jaroslaw Meller; Yi Zheng
Journal:  Chem Biol       Date:  2014-11-20

2.  Immunotherapy: Chemical tricks.

Authors:  Bianca Nogrady
Journal:  Nature       Date:  2014-09-11       Impact factor: 49.962

Review 3.  CAR T-cell therapy of solid tumors.

Authors:  Carmen S M Yong; Valerie Dardalhon; Christel Devaud; Naomi Taylor; Phillip K Darcy; Michael H Kershaw
Journal:  Immunol Cell Biol       Date:  2016-12-22       Impact factor: 5.126

4.  Targeted therapy for squamous cell lung cancer.

Authors:  Rachel G Liao; Hideo Watanabe; Matthew Meyerson; Peter S Hammerman
Journal:  Lung Cancer Manag       Date:  2012-12

5.  Tracking the Evolution of Non-Small-Cell Lung Cancer.

Authors:  Mariam Jamal-Hanjani; Gareth A Wilson; Nicholas McGranahan; Nicolai J Birkbak; Thomas B K Watkins; Selvaraju Veeriah; Seema Shafi; Diana H Johnson; Richard Mitter; Rachel Rosenthal; Max Salm; Stuart Horswell; Mickael Escudero; Nik Matthews; Andrew Rowan; Tim Chambers; David A Moore; Samra Turajlic; Hang Xu; Siow-Ming Lee; Martin D Forster; Tanya Ahmad; Crispin T Hiley; Christopher Abbosh; Mary Falzon; Elaine Borg; Teresa Marafioti; David Lawrence; Martin Hayward; Shyam Kolvekar; Nikolaos Panagiotopoulos; Sam M Janes; Ricky Thakrar; Asia Ahmed; Fiona Blackhall; Yvonne Summers; Rajesh Shah; Leena Joseph; Anne M Quinn; Phil A Crosbie; Babu Naidu; Gary Middleton; Gerald Langman; Simon Trotter; Marianne Nicolson; Hardy Remmen; Keith Kerr; Mahendran Chetty; Lesley Gomersall; Dean A Fennell; Apostolos Nakas; Sridhar Rathinam; Girija Anand; Sajid Khan; Peter Russell; Veni Ezhil; Babikir Ismail; Melanie Irvin-Sellers; Vineet Prakash; Jason F Lester; Malgorzata Kornaszewska; Richard Attanoos; Haydn Adams; Helen Davies; Stefan Dentro; Philippe Taniere; Brendan O'Sullivan; Helen L Lowe; John A Hartley; Natasha Iles; Harriet Bell; Yenting Ngai; Jacqui A Shaw; Javier Herrero; Zoltan Szallasi; Roland F Schwarz; Aengus Stewart; Sergio A Quezada; John Le Quesne; Peter Van Loo; Caroline Dive; Allan Hackshaw; Charles Swanton
Journal:  N Engl J Med       Date:  2017-04-26       Impact factor: 91.245

6.  Clonal status of actionable driver events and the timing of mutational processes in cancer evolution.

Authors:  Nicholas McGranahan; Francesco Favero; Elza C de Bruin; Nicolai Juul Birkbak; Zoltan Szallasi; Charles Swanton
Journal:  Sci Transl Med       Date:  2015-04-15       Impact factor: 17.956

Review 7.  The NF1 gene revisited - from bench to bedside.

Authors:  Yoon-Sim Yap; John R McPherson; Choon-Kiat Ong; Steven G Rozen; Bin-Tean Teh; Ann S G Lee; David F Callen
Journal:  Oncotarget       Date:  2014-08-15

8.  Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas.

Authors:  Joshua D Campbell; Anton Alexandrov; Jaegil Kim; Jeremiah Wala; Alice H Berger; Chandra Sekhar Pedamallu; Sachet A Shukla; Guangwu Guo; Angela N Brooks; Bradley A Murray; Marcin Imielinski; Xin Hu; Shiyun Ling; Rehan Akbani; Mara Rosenberg; Carrie Cibulskis; Aruna Ramachandran; Eric A Collisson; David J Kwiatkowski; Michael S Lawrence; John N Weinstein; Roel G W Verhaak; Catherine J Wu; Peter S Hammerman; Andrew D Cherniack; Gad Getz; Maxim N Artyomov; Robert Schreiber; Ramaswamy Govindan; Matthew Meyerson
Journal:  Nat Genet       Date:  2016-05-09       Impact factor: 38.330

9.  Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.

Authors:  Christopher Abbosh; Nicolai J Birkbak; Gareth A Wilson; Mariam Jamal-Hanjani; Tudor Constantin; Raheleh Salari; John Le Quesne; David A Moore; Selvaraju Veeriah; Rachel Rosenthal; Teresa Marafioti; Eser Kirkizlar; Thomas B K Watkins; Nicholas McGranahan; Sophia Ward; Luke Martinson; Joan Riley; Francesco Fraioli; Maise Al Bakir; Eva Grönroos; Francisco Zambrana; Raymondo Endozo; Wenya Linda Bi; Fiona M Fennessy; Nicole Sponer; Diana Johnson; Joanne Laycock; Seema Shafi; Justyna Czyzewska-Khan; Andrew Rowan; Tim Chambers; Nik Matthews; Samra Turajlic; Crispin Hiley; Siow Ming Lee; Martin D Forster; Tanya Ahmad; Mary Falzon; Elaine Borg; David Lawrence; Martin Hayward; Shyam Kolvekar; Nikolaos Panagiotopoulos; Sam M Janes; Ricky Thakrar; Asia Ahmed; Fiona Blackhall; Yvonne Summers; Dina Hafez; Ashwini Naik; Apratim Ganguly; Stephanie Kareht; Rajesh Shah; Leena Joseph; Anne Marie Quinn; Phil A Crosbie; Babu Naidu; Gary Middleton; Gerald Langman; Simon Trotter; Marianne Nicolson; Hardy Remmen; Keith Kerr; Mahendran Chetty; Lesley Gomersall; Dean A Fennell; Apostolos Nakas; Sridhar Rathinam; Girija Anand; Sajid Khan; Peter Russell; Veni Ezhil; Babikir Ismail; Melanie Irvin-Sellers; Vineet Prakash; Jason F Lester; Malgorzata Kornaszewska; Richard Attanoos; Haydn Adams; Helen Davies; Dahmane Oukrif; Ayse U Akarca; John A Hartley; Helen L Lowe; Sara Lock; Natasha Iles; Harriet Bell; Yenting Ngai; Greg Elgar; Zoltan Szallasi; Roland F Schwarz; Javier Herrero; Aengus Stewart; Sergio A Quezada; Karl S Peggs; Peter Van Loo; Caroline Dive; C Jimmy Lin; Matthew Rabinowitz; Hugo J W L Aerts; Allan Hackshaw; Jacqui A Shaw; Bernhard G Zimmermann; Charles Swanton
Journal:  Nature       Date:  2017-04-26       Impact factor: 49.962

Review 10.  The next generation of immunotherapy: keeping lung cancer in check.

Authors:  Ashwin Somasundaram; Timothy F Burns
Journal:  J Hematol Oncol       Date:  2017-04-24       Impact factor: 17.388

View more
  4 in total

1.  A Machine-Learning Approach to Developing a Predictive Signature Based on Transcriptome Profiling of Ground-Glass Opacities for Accurate Classification and Exploring the Immune Microenvironment of Early-Stage LUAD.

Authors:  Zhenyu Zhao; Wei Yin; Xiong Peng; Qidong Cai; Boxue He; Shuai Shi; Weilin Peng; Guangxu Tu; Yunping Li; Dateng Li; Yongguang Tao; Muyun Peng; Xiang Wang; Fenglei Yu
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

2.  miR-31 Displays Subtype Specificity in Lung Cancer.

Authors:  Mackenzie L Davenport; John B Echols; Austin D Silva; Joshua C Anderson; Philip Owens; Clayton Yates; Qing Wei; Shuko Harada; Douglas R Hurst; Mick D Edmonds
Journal:  Cancer Res       Date:  2021-02-08       Impact factor: 13.312

3.  Characterization of the Different Subtypes of Immune Cell Infiltration to Aid Immunotherapy.

Authors:  Zhenqing Li; Kai Mao; Bo Ding; Qun Xue
Journal:  Front Cell Dev Biol       Date:  2022-03-15

4.  Expression Of Intracellular Components of the NF-κB Alternative Pathway (NF-κB2, RelB, NIK and Bcl3) is Associated With Clinical Outcome of NSCLC Patients.

Authors:  Foteinos-Ioannis D Dimitrakopoulos; Anna G Antonacopoulou; Anastasia E Kottorou; Nikolaos Panagopoulos; Fotini Kalofonou; Fotios Sampsonas; Chrisoula Scopa; Melpomeni Kalofonou; Angelos Koutras; Thomas Makatsoris; Dimitrios Dougenis; Helen Papadaki; Malcolm Brock; Haralabos P Kalofonos
Journal:  Sci Rep       Date:  2019-10-04       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.